Shares of biotechnology firm Biocon on Monday surged over 7% after the company said it has received an EIR from the USFDA on closure of inspection of its aseptic drug product facility.
The stock soared 7.27% to settle at Rs 423 on BSE. During the day, it zoomed 7.74% to Rs 424.90 - its 52-week high. At NSE, shares of the company gained 7.31% to end at Rs 423.20.
In terms of equity volume, 7.55 lakh shares of the company were traded on BSE and over 80 lakh shares changed hands at NSE during the day.
Biocon on Monday said it has received the EIR (Establishment Inspection Report) with 'voluntary action indicated' status from the USFDA on closure of inspection of its aseptic drug product facility.
Published 20 November 2017, 15:36 IST